Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah R Kaye

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Urology|January 30, 2019
Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate CancerKevin B Ginsburg, Rohith Arcot, Ji Qi, et al.
The Journal of Surgical Research|January 30, 2019
Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive ProgramDeborah R Kaye, Rodney L Dunn, Jonathan Li, et al.
Cancer|July 1, 2017
Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgeryDeborah R Kaye, Edward C Norton, Chad Ellimoottil, et al.
Urology Practice|April 27, 2023
Association of Rural Hospital for-Profit Status With Higher Publicly Reported Prices for the Components of Inpatient Hematuria Evaluation Among Commercially Insured PatientsIan Berger, Vishnukamal Golla, Marcelo Cerullo, et al.
JCO Oncology Practice|February 19, 2020
Association Between Delivery System Structure and Intensity of End-of-Life Cancer CareLindsey A Herrel, Ziwei Zhu, Jennifer J Griggs, et al.
Annals of Surgery|January 3, 2019
Understanding the Costs Associated With Surgical Care Delivery in the Medicare PopulationDeborah R Kaye, Amy N Luckenbaugh, Mary Oerline, et al.
The American Journal of Managed Care|September 20, 2024
Systemic treatments for advanced prostate cancer: relationship between health insurance plan and treatment costsDeborah R Kaye, Hui-Jie Lee, Alexander Gordee, et al.
Journal of Medical Economics|January 11, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiationDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
JCO Oncology Practice|January 23, 2023
Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate CancerDeborah R Kaye, Hui-Jie Lee, Alexander Gordee, et al.
Urologic Oncology|April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World ExperienceAlireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Urology|January 30, 2019
Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate CancerKevin B Ginsburg, Rohith Arcot, Ji Qi, et al.
The Journal of Surgical Research|January 30, 2019
Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive ProgramDeborah R Kaye, Rodney L Dunn, Jonathan Li, et al.
Cancer|July 1, 2017
Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgeryDeborah R Kaye, Edward C Norton, Chad Ellimoottil, et al.
Urology Practice|April 27, 2023
Association of Rural Hospital for-Profit Status With Higher Publicly Reported Prices for the Components of Inpatient Hematuria Evaluation Among Commercially Insured PatientsIan Berger, Vishnukamal Golla, Marcelo Cerullo, et al.
JCO Oncology Practice|February 19, 2020
Association Between Delivery System Structure and Intensity of End-of-Life Cancer CareLindsey A Herrel, Ziwei Zhu, Jennifer J Griggs, et al.
Annals of Surgery|January 3, 2019
Understanding the Costs Associated With Surgical Care Delivery in the Medicare PopulationDeborah R Kaye, Amy N Luckenbaugh, Mary Oerline, et al.
The American Journal of Managed Care|September 20, 2024
Systemic treatments for advanced prostate cancer: relationship between health insurance plan and treatment costsDeborah R Kaye, Hui-Jie Lee, Alexander Gordee, et al.
Journal of Medical Economics|January 11, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiationDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
JCO Oncology Practice|January 23, 2023
Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate CancerDeborah R Kaye, Hui-Jie Lee, Alexander Gordee, et al.
Urologic Oncology|April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World ExperienceAlireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
Pageof 6